CyberCare Announces Approval of Transfer to Nasdaq Smallcap Market.

Business Editors/Medical & High Tech Writers

BOYNTON BEACH, Fla.--(BUSINESS WIRE)--June 14, 2002

CyberCare, Inc. (Nasdaq:CYBR), a holding company, primarily composed of a physical therapy and rehabilitation business, a pharmacy business, and a healthcare technology solutions business, today announced that it has received approval from The Nasdaq Stock Market to voluntarily transfer its listing to the SmallCap Market, effective at the opening of business today, June 14, 2002. CYBR will continue to be the trading symbol of the Company.

"We are very pleased that the transfer to The Nasdaq SmallCap Market has been approved. This move gives us until August 19, 2002 to complete the implementation of our strategic plan and path forward," stated Joe Forte, president and CEO. In granting approval, Nasdaq noted that CyberCare met all of the continued inclusion criteria for The Nasdaq SmallCap Market, except for the minimum $1.00 bid price per share requirement. However, as a result of the Company's transferring to The Nasdaq SmallCap Market, it was afforded a 180-calendar day grace period, which commenced on February 20, 2002. In addition, if by August 19, 2002 the Company is not in compliance with the minimum $1.00 bid price per share requirement, but is in compliance with the core initial listing criteria for The Nasdaq SmallCap Market, it may be granted an additional 180-calendar day grace period to demonstrate compliance with the minimum $1.00 bid price per share requirement. The Company noted that it believes it is currently in compliance with initial listing criteria for The Nasdaq SmallCap Market.

The SmallCap Market is well regulated and allows for the continued trading of CyberCare shares for the benefit of current and future shareowners.

About CyberCare, Inc.

CyberCare, Inc. is a holding company, which is primarily composed of a services business comprising both a physical therapy and rehabilitation business and a pharmacy business, and a healthcare technology solutions business. Our overall goal is to improve the delivery and quality of healthcare for patients while adding incremental value to our customers' clinical and business processes. Our physical therapy and rehabilitation business operates clinics throughout the State of Florida. Its caring staff of clinicians and therapists compliment traditional primary care, orthopedic and neurological physician services and serves a wide range of patients requiring physical and occupational therapy and other rehabilitation services. Our pharmacy business supports thousands of patients and residents in assisted living and other long-term care facilities located in Florida. It also is licensed for mail order distribution across all fifty states.

Our healthcare technology business utilizes its intellectual property, including patented technology, to deliver tele-health solutions addressing the entire continuum of care. It's Electronic HouseCall(R) (EHC(TM)) hardware and software technology focuses on the chronically ill, wellness management, compliance and wound care. The EHC(TM) family of products and services permit enhanced physician supervision and oversight and enable remote medical and wellness monitoring and real-time interactive communications between patients and caregivers. This is made possible through various monitoring devices, hardware and software applications and our ability to establish an interactive network across the health care continuum and among a community of users and providers. In combination with our customers' clinical and business processes, the Electronic HouseCall(R) system allows for effective and efficient data collection, integration and security, while successfully supporting case management and promoting personal participation and interaction. CyberCare, Inc. is headquartered in Boynton Beach, Florida. Visit our website at http://www.cybercare.net.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, product acceptance and effectiveness, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.